Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Voyager Therapeutics, Inc. (VT6.F)

2.7000
-0.0200
(-0.74%)
At close: 8:19:36 AM GMT+2
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
80,001
80,001
250,008
40,907
37,415
Operating Expense
163,288
163,288
127,994
91,744
111,033
Operating Income
-83,287
-83,287
122,014
-50,837
-73,618
Net Non Operating Interest Income Expense
18,328
18,328
11,721
1,792
-390
Other Income Expense
622
622
3
2,653
2,811
Pretax Income
-64,337
-64,337
133,738
-46,392
-71,197
Tax Provision
665
665
1,408
16
--
Net Income Common Stockholders
-65,002
-65,002
132,330
-46,408
-71,197
Diluted NI Available to Com Stockholders
-65,002
-65,002
132,330
-46,408
-71,197
Basic EPS
0.70
-1.13
3.08
-1.21
-1.89
Diluted EPS
0.66
-1.13
2.97
-1.21
-1.89
Basic Average Shares
55,472.4700
57,667.5430
43,020.7470
38,356.8100
37,668.9470
Diluted Average Shares
55,784.6010
57,667.5430
44,569.3340
38,356.8100
37,668.9470
Total Operating Income as Reported
-83,287
-83,287
122,014
-50,837
-73,618
Total Expenses
163,288
163,288
127,994
91,744
111,033
Net Income from Continuing & Discontinued Operation
-65,002
-65,002
132,330
-46,408
-71,197
Normalized Income
-65,002
-65,002
132,330
-46,408
-71,197
Net Interest Income
18,328
18,328
11,721
1,792
-390
EBIT
-83,287
-83,287
122,014
-50,837
-73,618
EBITDA
-78,556
-78,556
126,455
-44,646
-68,453
Reconciled Depreciation
4,731
4,731
4,441
6,191
5,165
Net Income from Continuing Operation Net Minority Interest
-65,002
-65,002
132,330
-46,408
-71,197
Normalized EBITDA
-78,556
-78,556
126,455
-44,646
-68,453
Tax Rate for Calcs
0.0002
0.0002
0
0.0002
--
12/31/2021 - 11/19/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers